DJ Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ slumped 0.31% to $48.99 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.20% to 5,070.55 and the Dow Jones Industrial Average rising 0.69% to 38,503.69.
The stock's fall snapped a three-day winning streak.
Bristol Myers Squibb Co. closed $21.95 short of its 52-week high ($70.94), which the company reached on April 25th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 0.30% to $149.56, Pfizer Inc. $(PFE)$ rose 0.23% to $26.32, and Abbott Laboratories $(ABT)$ rose 0.49% to $107.59.
Trading volume (9.1 M) remained 6.1 million below its 50-day average volume of 15.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 23, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 23, 2024 16:43 ET (20:43 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments